EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Volume 204 / Numéro 4 (2010) Biologie Aujourd'hui, 204 4 (2010) 295-300 References
Free Access
Issue
Biologie Aujourd'hui
Volume 204, Number 4, 2010
Page(s) 295 - 300
Section Les chimiokines : de nouveaux messagers communs entre système nerveux et système immunitaire
DOI https://doi.org/10.1051/jbio/2010023
Published online 10 janvier 2011
  • Apartis E., Trocello J.M., Skrzydelski D., Mélik-Parsadaniantz S., Sorokine A., Kitabgi P., Rostène W., Changes in SDF-1/CXCR4 and MCP-1/CCR2 expression in the substantia nigra of the 6-hydroxydopamine-lesioned rat. Communication à la Société des Neurosciences. Mai 2005, Lille. [Google Scholar]
  • Banisadr G., Quéraud-Lesaux F., Boutterin M.C., Pélaprat D., Zalc B., Rostène W., Haour F., Parsadaniantz S.M., Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem, 2002a, 81, 257–269. [CrossRef] [PubMed] [Google Scholar]
  • Banisadr G., Fontanges P., Haour F., Kitabgi P., Rostène W., Mélik-Parsadaniantz S., Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci, 2002b, 16, 1661–1671. [CrossRef] [PubMed] [Google Scholar]
  • Banisadr G., Skrzydelski D., Kitabgi P., Rostène W., Parsadaniantz S.M., Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain : constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci, 2003, 18, 1593–1560. [CrossRef] [PubMed] [Google Scholar]
  • Banisadr G., Gosselin R., Mechighel P., Kitabgi P., Rostène W., Mélik-Parsadaniantz S., Highly regionalized neuronal expression of MCP-1/CCL2 in rat brain. Evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol, 2005, 489, 275–292. [CrossRef] [PubMed] [Google Scholar]
  • Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A., CXCR4-activated astrocyte glutamate release via TNFalpha : amplification by microglia triggers neurotoxicity. Nat Neurosci, 2001, 4, 702–710. [CrossRef] [PubMed] [Google Scholar]
  • Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 1996, 382, 829–833. [CrossRef] [PubMed] [Google Scholar]
  • Brouard A., Pélaprat D., Dana C., Vial M., Lhiaubet A.M., Rostène W., Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors. Neuroscience, 1992, 12, 1409–1415. [PubMed] [Google Scholar]
  • Callier S., Le Saux M., Lhiaubet A.M., Di Paolo T., Rostène W., Pélaprat D., Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture. J Neurochem, 2002, 80, 307–316. [CrossRef] [PubMed] [Google Scholar]
  • Cicchetti F., Brownell A.L., William K., Chen Y.I., Livni E., Isacson O., Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci, 2002, 15, 991–998. [CrossRef] [PubMed] [Google Scholar]
  • Guyon A., Skrzydelski D., Rovère C., Rostène W., Mélik-Parsadaniantz S., Nahon J.L., Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones : presynaptic mechanisms. J Neurochem, 2006, 96, 1540–1550. [CrossRef] [PubMed] [Google Scholar]
  • Guyon A., Skrzydelski D., Rovère C., Apartis E., Rostène W., Kitabgi P., Mélik-Parsadaniantz S., Nahon J.L., Stromal-cell-derived factor1alpha/CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur J Neurosci, 2008, 28, 862–870. [CrossRef] [PubMed] [Google Scholar]
  • Guyon A., Skrzydelski D., De Giry I., Rovère C., Conductier G., Trocello J.M., Daugé V., Kitabgi P., Rostène W., Nahon J.L., Mélik-Parsadaniantz S., Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system : a novel mechanism for the control of dopamine release. Neuroscience, 2009, 15, 1072–1080. [CrossRef] [Google Scholar]
  • Hébert G., Arsaut J., Dantzer R., Demotes-Mainard J., Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, a dopaminergic neurotoxin. Neurosci Lett, 2003, 349, 191–195. [CrossRef] [PubMed] [Google Scholar]
  • Hirsch E.C., Glial cells and Parkinson’s disease. J Neurol, 2000, 247, II/58–II/62. [Google Scholar]
  • Kaul M., Garden G.A., Lipton S.A., Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 2001, 410, 988–994. [CrossRef] [PubMed] [Google Scholar]
  • Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., Czlonkowska A., The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse. Exp Neurol, 1999, 156, 50–61. [CrossRef] [PubMed] [Google Scholar]
  • Limatola C., Giovannelli A., Maggi L., Ragozzino D., Castellani L., Ciotti M.T., Vacca F., Mercanti D., Santoni A., Eusebi, F., SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur J Neurosci, 2000, 12, 2497–2504. [CrossRef] [PubMed] [Google Scholar]
  • Lorenzl S., Albers D.S., Narr S., Chirichigno J., Beal M.F., Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson’s disease. Exp Neurol, 2002, 178, 13–20. [CrossRef] [PubMed] [Google Scholar]
  • Lorenzl S., Calingasan N., Yang L., Albers D.S., Shugama S., Gregorio J., Krell H.W., Chirichigno J., Joh T., Beal M.F., Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in mice. Neuromolecular Med, 2004, 5, 119–132. [CrossRef] [PubMed] [Google Scholar]
  • Meucci O., Fatatis A., Simen A.A., Miller R.J., Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA, 2000, 97, 8075–8080. [CrossRef] [Google Scholar]
  • McQuibban G.A., Butler G.S., Gong G.H., Bendall L., Power C., Clark-Lewis I., Overall C.M., Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem, 2001, 276, 43503–43508. [CrossRef] [PubMed] [Google Scholar]
  • Nagatsu T., Mogi M., Ichinose H., Togari A., Cytokines in Parkinson’s disease. J Neural Transm Suppl., 2000, 58, 143–51. [PubMed] [Google Scholar]
  • Oberlin E., Amara A., Bachèlerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B., The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature, 1996, 382, 833–835. Erratum in : Nature 1996, 384, 288. [CrossRef] [PubMed] [Google Scholar]
  • Pycock C.J., Turning behaviour in animals. Neuroscience, 1980, 5, 461–514. [CrossRef] [PubMed] [Google Scholar]
  • Skrzydelski D., Guyon A., Dauge V., Rovère C., Apartis E., Kitabgi P., Nahon J.L., Rostène W., Mélik-Parsadaniantz S., The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem, 2007, 102, 1175–1183. [CrossRef] [PubMed] [Google Scholar]
  • Valenzuela-Fernandez A., Planchenault T., Baleux F., Staropoli I., Le Barillec K., Leduc D., Delaunay T., Lazarini F., Virelizier J.L., Chignard M., Pidard D., Arenzana-Seisdedos F., Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem, 2002, 277, 15677–15689. [CrossRef] [PubMed] [Google Scholar]
  • Vila M., Jackson-Lewis V., Guégan C., Wu D.C., Teismann P., Choi D.K., Tieu K., Przedborski S., The role of glial cells in Parkinson’s disease. Curr Opin Neurol, 2001, 14, 483–489. [CrossRef] [PubMed] [Google Scholar]
  • Shimoji M., Pagan F., Healton E.B., Mochetti I., CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson’s disease. Neurotox Res, 2009, 16, 318–328. [CrossRef] [PubMed] [Google Scholar]
  • Vergote D., Butler G.S., Ooms M., Cox J.H., Silva C., Hollenberg M.D., Jhamandas J.H., Overall C.M., Power C., Proteolytic processing of SDF-1a reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc Nat Acad Sci USA, 2006, 103, 19182–19187. [Google Scholar]
  • Wightman R.M., Robinson D.L., Transient changes in mesolimbic dopamine and their association with “reward”. J Neurochem, 2002, 82, 721–35. [CrossRef] [PubMed] [Google Scholar]
  • Zhang K., McQuibban G.A., Silva C., Butler G.S., Johnston J.B., Holden J., Clark-Lewis I., Overall C.M., Power C., HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nature Neurosci, 2003, 6, 1064–1070. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.